Literature DB >> 23775067

Cell cycle activation contributes to increased neuronal activity in the posterior thalamic nucleus and associated chronic hyperesthesia after rat spinal cord contusion.

Junfang Wu1, Charles Raver, Chunshu Piao, Asaf Keller, Alan I Faden.   

Abstract

Spinal cord injury (SCI) causes not only sensorimotor and cognitive deficits, but frequently also severe chronic pain that is difficult to treat (SCI pain). We previously showed that hyperesthesia, as well as spontaneous pain induced by electrolytic lesions in the rat spinothalamic tract, is associated with increased spontaneous and sensory-evoked activity in the posterior thalamic nucleus (PO). We have also demonstrated that rodent impact SCI increases cell cycle activation (CCA) in the injury region and that post-traumatic treatment with cyclin dependent kinase inhibitors reduces lesion volume and motor dysfunction. Here we examined whether CCA contributes to neuronal hyperexcitability of PO and hyperpathia after rat contusion SCI, as well as to microglial and astroglial activation (gliopathy) that has been implicated in delayed SCI pain. Trauma caused enhanced pain sensitivity, which developed weeks after injury and was correlated with increased PO neuronal activity. Increased CCA was found at the thoracic spinal lesion site, the lumbar dorsal horn, and the PO. Increased microglial activation and cysteine-cysteine chemokine ligand 21 expression was also observed in the PO after SCI. In vitro, neurons co-cultured with activated microglia showed up-regulation of cyclin D1 and cysteine-cysteine chemokine ligand 21 expression. In vivo, post-injury treatment with a selective cyclin dependent kinase inhibitor (CR8) significantly reduced cell cycle protein induction, microglial activation, and neuronal activity in the PO nucleus, as well as limiting chronic SCI-induced hyperpathia. These results suggest a mechanistic role for CCA in the development of SCI pain, through effects mediated in part by the PO nucleus. Moreover, cell cycle modulation may provide an effective therapeutic strategy to improve reduce both hyperpathia and motor dysfunction after SCI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23775067      PMCID: PMC3701760          DOI: 10.1007/s13311-013-0198-1

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  86 in total

1.  Pain following spinal cord injury.

Authors:  R Defrin; A Ohry; N Blumen; G Urca
Journal:  Spinal Cord       Date:  2002-02       Impact factor: 2.772

2.  Review of clinical trials of neuroprotection in acute spinal cord injury.

Authors:  C H Tator; M G Fehlings
Journal:  Neurosurg Focus       Date:  1999-01-15       Impact factor: 4.047

3.  Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats.

Authors:  Megan Ryan Detloff; Lesley C Fisher; Violetta McGaughy; Erin E Longbrake; Phillip G Popovich; D Michele Basso
Journal:  Exp Neurol       Date:  2008-04-20       Impact factor: 5.330

4.  Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma.

Authors:  Shruti V Kabadi; Bogdan A Stoica; Kimberly R Byrnes; Marie Hanscom; David J Loane; Alan I Faden
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-10       Impact factor: 6.200

5.  Gene profiling in spinal cord injury shows role of cell cycle in neuronal death.

Authors:  Simone Di Giovanni; Susan M Knoblach; Cinzia Brandoli; Sadia A Aden; Eric P Hoffman; Alan I Faden
Journal:  Ann Neurol       Date:  2003-04       Impact factor: 10.422

6.  Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment.

Authors:  Kevin D Beck; Hal X Nguyen; Manuel D Galvan; Desirée L Salazar; Trent M Woodruff; Aileen J Anderson
Journal:  Brain       Date:  2010-01-19       Impact factor: 13.501

7.  Zona incerta: a role in central pain.

Authors:  Radi Masri; Raimi L Quiton; Jessica M Lucas; Peter D Murray; Scott M Thompson; Asaf Keller
Journal:  J Neurophysiol       Date:  2009-04-29       Impact factor: 2.714

8.  Alterations in burst firing of thalamic VPL neurons and reversal by Na(v)1.3 antisense after spinal cord injury.

Authors:  Bryan C Hains; Carl Y Saab; Stephen G Waxman
Journal:  J Neurophysiol       Date:  2006-02-15       Impact factor: 2.714

9.  Delayed inflammatory mRNA and protein expression after spinal cord injury.

Authors:  Kimberly R Byrnes; Patricia M Washington; Susan M Knoblach; Eric Hoffman; Alan I Faden
Journal:  J Neuroinflammation       Date:  2011-10-05       Impact factor: 8.322

10.  Inhibition of E2F1/CDK1 pathway attenuates neuronal apoptosis in vitro and confers neuroprotection after spinal cord injury in vivo.

Authors:  Junfang Wu; Giorgi Kharebava; Chunshu Piao; Bogdan A Stoica; Michael Dinizo; Boris Sabirzhanov; Marie Hanscom; Kelsey Guanciale; Alan I Faden
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more
  21 in total

Review 1.  Neuropathic Pain After Spinal Cord Injury: Challenges and Research Perspectives.

Authors:  Rani Shiao; Corinne A Lee-Kubli
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

Review 2.  Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury.

Authors:  Alan I Faden; Junfang Wu; Bogdan A Stoica; David J Loane
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

3.  Does time heal all wounds? Experimental diffuse traumatic brain injury results in persisting histopathology in the thalamus.

Authors:  Theresa Currier Thomas; Sarah B Ogle; Benjamin M Rumney; Hazel G May; P David Adelson; Jonathan Lifshitz
Journal:  Behav Brain Res       Date:  2016-12-29       Impact factor: 3.332

4.  Endoplasmic Reticulum Stress and Disrupted Neurogenesis in the Brain Are Associated with Cognitive Impairment and Depressive-Like Behavior after Spinal Cord Injury.

Authors:  Junfang Wu; Zaorui Zhao; Alok Kumar; Marta M Lipinski; David J Loane; Bogdan A Stoica; Alan I Faden
Journal:  J Neurotrauma       Date:  2016-05-16       Impact factor: 5.269

5.  Spinal cord injury causes brain inflammation associated with cognitive and affective changes: role of cell cycle pathways.

Authors:  Junfang Wu; Zaorui Zhao; Boris Sabirzhanov; Bogdan A Stoica; Alok Kumar; Tao Luo; Jacob Skovira; Alan I Faden
Journal:  J Neurosci       Date:  2014-08-13       Impact factor: 6.167

6.  Isolated spinal cord contusion in rats induces chronic brain neuroinflammation, neurodegeneration, and cognitive impairment. Involvement of cell cycle activation.

Authors:  Junfang Wu; Bogdan A Stoica; Tao Luo; Boris Sabirzhanov; Zaorui Zhao; Kelsey Guanciale; Suresh K Nayar; Catherine A Foss; Martin G Pomper; Alan I Faden
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  Ablation of the transcription factors E2F1-2 limits neuroinflammation and associated neurological deficits after contusive spinal cord injury.

Authors:  Junfang Wu; Boris Sabirzhanov; Bogdan A Stoica; Marta M Lipinski; Zaorui Zhao; Shuxin Zhao; Nicole Ward; Dianer Yang; Alan I Faden
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

8.  Disrupted autophagy after spinal cord injury is associated with ER stress and neuronal cell death.

Authors:  S Liu; C Sarkar; M Dinizo; A I Faden; E Y Koh; M M Lipinski; J Wu
Journal:  Cell Death Dis       Date:  2015-01-08       Impact factor: 8.469

9.  Cell cycle inhibition limits development and maintenance of neuropathic pain following spinal cord injury.

Authors:  Junfang Wu; Zaorui Zhao; Xiya Zhu; Cynthia L Renn; Susan G Dorsey; Alan I Faden
Journal:  Pain       Date:  2016-02       Impact factor: 7.926

10.  Blast-induced brain injury in rats leads to transient vestibulomotor deficits and persistent orofacial pain.

Authors:  Paige E Studlack; Kaspar Keledjian; Tayyiaba Farooq; Titilola Akintola; Volodymyr Gerzanich; J Marc Simard; Asaf Keller
Journal:  Brain Inj       Date:  2018-10-22       Impact factor: 2.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.